Real-World Experience with High- versus Low-Dose Polymyxin B for Pulmonary Infections: A Retrospective Cohort Study
{{output}}
Background: Polymyxin B(PMB) is crucial for treating carbapenem-resistant Gram-negative pulmonary infections. Despite existing guidelines, real-world dosing varies widely. The clinical and economic outcomes associated with higher... ...
